Trials / Recruiting
RecruitingNCT05365815
Melanated Group Midwifery Care (MGMC)
Black Midwives for Black Women: Maternity Care to Improve Trust and Attenuate Structural Racism
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 432 (estimated)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- Female
- Age
- 15 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to determine if a multi-level intervention for delivering maternity care can improve patient trust and engagement among Black birthing people.
Detailed description
Low-risk pregnant participants will be randomized into Melanated Group Midwifery Care or usual individualized obstetric care. In Melanated Group Midwifery Care (MGMC), Black women will receive prenatal care from a Black midwife in groups with the same 8-10 other Black women throughout pregnancy. In pregnancy and into the first year postpartum, MGMC patients will stay connected to the health system through a proactive care coordinator, who is a Black licensed nurse. For the first year after giving birth, patients in MGMC will also be supported by a trained postpartum doula. All participants (intervention and usual care groups) will complete study measures that include validated surveys on patient trust, respect and engagement at 6 time points: * 3 time points in pregnancy \[baseline (\<20 weeks), 26-28 weeks, and 35- 37 weeks\] and * 3 in the postpartum at 2-, 6-, and 12-months * Additional qualitative interviews will be done to track the care received by medically and socially complex patients, including all who experience a severe maternal morbidity. The investigators will also document how MGMC gets embedded in practice through a qualitative process evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Melanated Group Midwifery Care | Racially concordant maternity care Group prenatal care Racially concordant nursing care coordination Postpartum doula support |
Timeline
- Start date
- 2022-06-08
- Primary completion
- 2026-05-15
- Completion
- 2027-02-01
- First posted
- 2022-05-09
- Last updated
- 2024-07-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05365815. Inclusion in this directory is not an endorsement.